|Spider web by Luc Viatour / www.Lucnix.be|
Regular readers of this blog might already understand that I have a continued interested in the output from the MIND Institute with autism in mind, much of which has been summarised in another paper from Dr Onore** on the role of the immune system in cases of autism. Indeed just reading the abstract to this summary paper makes me further realise how complex and 'real' the immune system findings are to autism - some cases of autism. These are not just funny abbreviations like IL-6 or INF but very real elements to what is a very complicated condition. An interesting opinion piece arrives at similar conclusions.
Anyway, back to the topic/paper at hand, cell adhesion, and probably best if I try and translate a few of the concepts outlined in the recent paper as well as summarising what was found, just so you know how the findings might fit in.
- 'leukocyte transendothelial migration' basically refers to the process of getting leukocytes (white blood cells) to the site of infection or injury. If you can bear some pretty heavy biochemistry, this paper by Liu and colleagues*** (full-text) offers quite a detailed description of what's potentially involved in the process.
- 'Levels of sPECAM-1 and sP-selectin were significantly reduced in the ASD group'. The selectins are kinda the first response in recruiting leukocytes to where they're needed. From what I can gather, they 'tether' white blood cells (leukocytes) to the endothelial cells to facilitate rolling to the site of injury and inflammation (see here). I suppose it's kinda like a velcro response although perhaps not so permanent (see here). Lower levels of [plasma soluble] sP-selectin might indicate some issue with the ability to perform these adhesive duties bearing in mind that the other selectins, L-selectin and E-selectin also play an important role. Given the link between elevations of sP-selectin as a marker for platelet / endothelial activation (among other things), one has to suggest that these results are perhaps reflective of hypo-activation compared with controls. Similar findings have been reported previously**** (full-text).
- Lower levels of platelet endothelial adhesion molecule-1 (PECAM-1) (see here for a good overview) were also reported. PECAM-1 seems to perform a similar role with regards to adhesion. Interestingly, this is again not the first time that lower levels of PECAM-1 have been reported in cases of autism*****.
- "Soluble PECAM-1 levels were negatively associated with repetitive behavior and abnormal brain growth in children with ASD (p = .03)". In other words, low levels of PECAM-1 were linked to elevated levels of repetitive behaviours and unusual head growth (again as per the Tsuchuiya findings).
I can't claim to be a world's expert on this area of autism research so won't go to far further into the possible meaning. The authors conclude that these adhesion molecules "modulate the permeability and signaling at the blood-brain barrier". That is true as per reviews like this one from Kalinowska & Losy****** on PECAM-1 and neuroinflammation. Unless I'm reading this wrong, the only issue being that elevated levels of PECAM-1 seem to be related to such issues; the current results were kinda sailing against that tide at least in their cohort as a group.
Taken at face value, these results may suggest that the various ways and means that the body deals with inflammation may be perturbed in some cases of autism. Without actually knowing whether inflammation (acute or chronic) was present in the described cases of the current study, it is slightly difficult to make too much of the findings as they stand. Reiterating that the involvement of the immune system in cases of autism is far from simple - some say presentation of under-activation (as per this article on the immunoglobulins by the MIND Institute) others say over-activation (see here) - one has to be cautious about making sweeping generalisations. Realising also that the immune system is not just one system, as per the innate vs. adaptive classifications.
A final note. One added bonus to the current paper was the relationship with the Autism Phenome Project (APP) which very importantly realises that autism is an umbrella term to describe lots and lots of different presentations; not necessarily all the same thing however in terms of aetiology or trajectory (see the 'bloomers' post). Indeed based on the previous results reported for the APP looking at brain enlargement and regression in autism (see here), there is perhaps some overlap in participants taking part in the current study also.
To finish, the sad news of the death of a true icon of the age, Neil Armstrong, brings to mind an apt song, Man on the Moon by REM. Truly one small step, one giant leap.
* Onore CE. et al. Levels of soluble platelet endothelial cell adhesion molecule-1 and P-selectin are decreased in children with autism spectrum disorder. Biological Psychiatry. June 2012.
** Onore CE. et al. The role of immune dysfunction in the pathophysiology of autism. Brain, Behavior & Immunity. 2012; 36: 383-392.
*** Liu Y. et al. Regulation of leukocyte transmigration: cell surface interactions and signaling events. Journal of Immunology. 2004; 172: 7-13.
**** Iwata Y. et al. Serum levels of P-selectin in men with high-functioning autism. British Journal of Psychiatry. 2008; 193: 338-339.
**** Tsuchuiya KJ. et al. Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birth. Biological Psychiatry. 2007; 62: 1056-1058.
***** Kalinowska A. & Losy J. PECAM-1, a key player in neuroinflammation. European Journal of Neurology. 2006; 13: 1284-1290.
Onore CE, Nordahl CW, Young GS, Van de Water JA, Rogers SJ, & Ashwood P (2012). Levels of Soluble Platelet Endothelial Cell Adhesion Molecule-1 and P-Selectin Are Decreased in Children with Autism Spectrum Disorder. Biological Psychiatry PMID: 22717029
Post a Comment
Note: only a member of this blog may post a comment.